| AKT1 Mutation Analysis (E17K) |
MG3004 |
5 ml Blood or 3 ml Bone marrow in K2 EDTA Tube (LCT) |
Tue |
7 days |
Molecular Genetics |
| AneuFiSH-5 Markers Chromosomal 13, 18, 21, X, Y Aneuploidy Screen (VB) |
CG2063 |
5 ml Venous Blood Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| BRAF Target Exon Analysis (Exon 11 & 15) |
MG3011 |
ST: FFPE or Tumor Tissue or FNA; HC: 5 ml Blood or 3 ml Bone marrow |
Daily |
7 days |
Molecular Genetics |
| BRAF V600E Mutation Analysis |
MG3012 |
ST: FFPE or Tumor Tissue or FNA; HC: 5 ml Blood or 3 ml Bone marrow |
Daily |
7 days |
Molecular Genetics |
| Calreticulin (CALR) Mutation Analysis |
MG3013 |
4 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Daily |
8 days |
Molecular Genetics |
| CEBPA Mutation Analysis |
MG3014 |
5 ml Blood or 3 ml Bone marrow in EDTA Vacut. (PCT) |
Mon |
10 days |
Molecular Genetics |
| Chromosomal Analysis - Karyotyping (BM) |
CG2018 |
2 ml Bone Marrow in Sod. Heparin Tube (GCT) |
Daily |
21 days |
Cytogenetics |
| Chromosomal Analysis - Karyotyping (Hematological Cancers) |
CG2020 |
5-10 mL blood in Sod.Heparin Tube (GCT) |
Daily |
15 days |
Cytogenetics |
| Chromosomal Analysis - Karyotyping (VB) |
CG2021 |
5 mL Venous blood in Sod. Heparin Tube (GCT) |
Daily |
15 days |
Cytogenetics |
| Chromosomal Analysis - Karyotyping, Couples (VB) |
CG2022 |
5 mL Venous blood in Sod. Heparin Tube (GCT) |
Daily |
15 days |
Cytogenetics |
| Chromosomal Analysis HR Karyotyping (High Resolution Banding) |
CG2023 |
5 mL Blood Sod.Heparin Tube (GCT) |
Daily |
21 days |
Cytogenetics |
| Chromosomal Analysis, Karyotyping with reflex FISH (POC) |
CG2024 |
Products of Conception (POC) in Sterile Specimen Container (SSC) having Saline+5 drops gentamycin |
Daily |
21 days |
Cytogenetics |
| Chromosomal Breakage Analysis |
CG2025 |
5 mL Blood Sod. Heparin Tube (GCT) |
Daily |
21 days |
Cytogenetics |
| CSF3R Mutation Analysis |
MG3129 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT), Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
7 days |
Molecular Genetics |
| CTNNB1 Mutation Analysis |
MG3128 |
Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
7 days |
Molecular Genetics |
| DPD Gene Mutation for 5-Fluorouracil Toxicity Test (DPYD IVS14+1G>A) |
MG3021 |
5 ml Blood K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| EGFR Target Exons Sequencing (Exon 18, 19, 20, & 21) |
MG3022 |
Tumor Tissue or FFPE Block or FNA |
Daily |
5 days |
Molecular Genetics |
| Factor V Leiden Mutation Analysis (FVL-R506Q) |
MG3024 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| FIP1L1-PDGFR-A Gene Rearrangement PCR |
MG3096 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT), Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Sat |
15 days |
Molecular Genetics |
| FiSH - Sex Mismatch X, Y Chromosome (Post BMT) |
CG2030 |
2 ml Bone Marrow Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| FLT3 Mutation Analysis (ITD & D835Y) |
MG3023 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Wed,Sat |
5 days |
Molecular Genetics |
| GNAS Mutation Analysis (Codon 201 & 227) Exon 8 & 9 |
MG3029 |
FFPE OR Fresh tumor tissue |
Daily |
7 days |
Molecular Genetics |
| HmLH-1 & HMSH-2 (Repair Genes) Molecular Analysis |
MG3028 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| HRAS Mutation Analysis |
MG3044 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| IDH1 & IDH2 Target Mutation Analysis |
MG3047 |
FFPE Block or Tumor Tissue/ 5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| Imatinib Resistance Mutation Analysis (IRMA) |
MG3048 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Fri |
7 days |
Molecular Genetics |
| Inv 16 - t(16-16) (p13q22) Gene Rearrangement Qualitative PCR |
MG3095 |
3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] |
Wed, Sat |
7 days |
Molecular Genetics |
| JAK2 Exon 12 Sequence Analysis |
MG3049 |
5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| JAK2 Target Exons Sequence Analysis |
MG3050 |
5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| JAK2 V617F Mutation Analysis |
MG3100 |
5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| KIT Exon 17 Mutation Analysis |
MG3126 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT), Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
7 days |
Molecular Genetics |
| KRAS One Mutation Analysis |
MG3053 |
Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
7 days |
Molecular Genetics |
| KRAS Target Exons Screening |
MG3051 |
Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Tue,Fri |
10 days |
Molecular Genetics |
| KRAS Two Mutation Analysis |
MG3052 |
Daily |
7 days |
7 days |
Molecular Genetics |
| MPL1 Mutation Analysis (Myeloproliferative Leukemia) |
MG3054 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| Nonsyndromic Hearing loss Mutation Analysis (Connexin-26) |
MG3120 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| NRAS Target Exon Sequence Analysis |
MG3058 |
Tumor Tissue or FFPE Block |
Mon |
7 days |
Molecular Genetics |
| OncoFiSH - 7q deletion Analysis; (7q22;7q36) MDS & AML |
CG2048 |
5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| OncoFiSH - ALK Gene Rearrangement |
CG2049 |
FFPE (Formalin Fixed Paraffin Embedded) Tissue Block |
Daily |
12 days |
Cytogenetics |
| OncoFiSH - ATM Deletion; del(11) (q22.3) (NHL) |
CG2066 |
5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) |
Mon, Thu |
7 days |
Cytogenetics |
| OncoFiSH - BCR-ABL1; t(9;22)(q34;q11.2) (CML) |
CG2050 |
5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| OncoFiSH - cMYC Ampliciation |
CG2070 |
5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT); FFPE Block in Sterile Container |
Daily |
7 days |
Cytogenetics |
| OncoFiSH - EGFR Gene Amplification |
CG2051 |
FFPE (Formalin Fixed Paraffin Embedded) Tissue Block |
Daily |
10 days |
Cytogenetics |
| OncoFiSH - ERBB2 (HER-2/neu) Gene Amplification (Breast Cancer) |
CG2052 |
Fresh Tumor tissue, FNA, FFPE (Paraffin Embedded Tissue Blocks) |
Wed, Sat |
10 days |
Cytogenetics |
| OncoFiSH - ETV6-RUNX1 (TEL-AML1); t(12;21) (p13;q22) |
CG2067 |
5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) |
Mon, Thu |
7 days |
Cytogenetics |
| OncoFiSH - FGFR3-IGH Fusion; t(4;14)(p16;q32) (NHL) |
CG2054 |
3 ml Bone Marrow or 5 ml Blood Sod. Heparin Tube (GCT) |
Mon, Thu |
7 days |
Cytogenetics |
| OncoFiSH - IGH Rearrangement; 14q32.3 (ALL / AML) |
CG2055 |
5 ml Blood Sod. Heparin Tube (GCT) |
Mon, Thu |
7 days |
Cytogenetics |
| OncoFiSH - IGH-CCND1 Fusion; t(11;14) Mantle Cell Lymphoma (MCL) |
CG2056 |
3 ml Blood In Sodium Heparin Vacutainer |
Daily |
7 days |
Cytogenetics |
| OncoFiSH - IGH-MYC Dual Fusion t(8;14) (Burkitt\'s Lymphoma) |
CG2057 |
ST: FFPE or Tumor Tissue or FNA; HC: 5 ml Blood or 3 ml Bone marrow in Heparin Tube (GCT) |
Mon, Thu |
7 days |
Cytogenetics |
| OncoFiSH - Inv (16) - CBFB Inversion; t(16;16) (p13;q22) (AML) |
CG2058 |
5 ml Blood Sod. Heparin Tube (GCT) |
Mon, Thu |
6 days |
Cytogenetics |
| OncoFiSH - KMT2A (MLL) Break-apart Analysis; 11q23 (AML & ALL) |
CG2059 |
5 ml Blood or 2 ml Bone Marrow Sod.Heparin Tube (GCT) |
Mon, Thu |
7 days |
Cytogenetics |
| OncoFiSH - MYC Break-apart Analysis; 8q24 (B-cell malignancies) |
CG2060 |
5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT); FFPE Block in Sterile Container |
Daily |
7 days |
Cytogenetics |
| OncoFiSH - PML-RARA; t(15;17) (q22;q21.1) (AML) |
CG2064 |
5 ml Blood or 2 ml Bone Marrow Sod.Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| OncoFiSH - RB1-LAMP; 13q34 Deletion |
CG2061 |
5 ml Blood or 2 ml Bone Marrow Sod.Heparin Tube (GCT) |
Mon, Thu |
7 days |
Cytogenetics |
| OncoFiSH - RUNX1T1-RUNX1 (ETO-AML1); t(8;21) (AML) |
CG2065 |
5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| OncoFiSH - TP53 Deletion ; 17p13 Deletion (CLL) |
CG2062 |
5 ml Blood or 2 ml Bone Marrow Sod.Heparin Tube (GCT) |
Mon, Thu |
7 days |
Cytogenetics |
| OncoFiSH ALK1-ROS1 Rearrangement (FISH for Non Small Cell Lung Cancer-NSCLC) |
CG2053 |
FFPE Block; Fresh Tumor Tissue in Normal Saline; FNA on Slide |
Daily |
12 days |
Cytogenetics |
| PDGFR Alpha Gene Rearrangement; 4q12 |
CG2068 |
5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) |
Daily |
8 days |
Cytogenetics |
| PDGFR Beta Gene Rearrangement; 5q33 |
CG2069 |
5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) |
Daily |
8 days |
Cytogenetics |
| PDGFRA Target Exon Sequence Analysis |
MG3127 |
5 ml Blood or 3 ml Bone marrow in EDTA Vacut. (PCT) or FFPE or Tumor Tissue or FNA |
Daily |
7 days |
Molecular Genetics |
| PDGFRA Target Exons Sequence Analysis |
MG3060 |
Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
10 days |
Molecular Genetics |
| PIK3CA Target Mutation Analysis |
MG3061 |
Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
7 days |
Molecular Genetics |
| Platinum Drug Response Genetic Test (GSTP1, XRCC1, ERCC2) |
MG3062 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| RET High Risk Mutation (Exon 10 &11) |
MG3064 |
FFPE or Tumor Tissue or FNA; 5ml Blood for Family Screening |
Daily |
7 days |
Molecular Genetics |
| t(11;19) (q23;p13.3); (MLL-ENL), Qualitative PCR |
MG3091 |
3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] |
Wed, Sat |
5 days |
Molecular Genetics |
| t(12;21) (p13;q22); ETV6-RUNX1(TEL-AML1), Qualitative PCR |
MG3092 |
3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] |
Wed, Sat |
5 days |
Molecular Genetics |
| t(15;17) (q22;q12) PML-RARA Qualitative PCR |
MG3093 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Tue, Thu, Sat |
3 days |
Molecular Genetics |
| t(15;17) (q22;q12) PML-RARA Quantitative PCR |
MG3094 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Tue, Thu, Sat |
5 days |
Molecular Genetics |
| t(1;19) (q23;p13.3); TCF3-PBX1 (E2A-PBX1), Qualitative PCR |
MG3080 |
3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] |
Wed, Sat |
5 days |
Molecular Genetics |
| t(4;11) (q21;q23); (MLL-AF4), Qualitative PCR |
MG3081 |
3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] |
Wed, Sat |
5 days |
Molecular Genetics |
| t(5;12) ; PDGFRB-ETV6 Gene Rearrangement - PCR |
MG3082 |
5ml Blood / 2ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| t(8;21) ; AML1-ETO Qualitative PCR |
MG3084 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Wed, Sat |
5 days |
Molecular Genetics |
| t(9:22) ; BCR-ABL Qualitative PCR |
MG3085 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Tue, Thu, Sat |
3 days |
Molecular Genetics |
| t(9:22) ; BCR-ABL Quantitative (IS-International Scale) |
MG3086 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Tue, Thu, Sat |
5 days |
Molecular Genetics |
| t(9;11) (p21-22;q23); (MLL-AF9), Qualitative PCR |
MG3087 |
3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] |
Wed, Sat |
5 days |
Molecular Genetics |
| Tamoxifen Drug Response Test (CYP2D6 Genotype Analysis) |
MG3079 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| Waldenstrom macroglobulinemia Molecular Analysis |
MG3130 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT), Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
7 days |
Molecular Genetics |
| WT1 Gene Mutation Analysis (Wilm's Tumor) (Exon 7 & 9) |
MG3098 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
